noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Science

Promega Corporation

Promega Launches Paradyme™ 27GY STR System, Minimizing Stutter[...]
Ollin Biosciences Inc

Ollin Biosciences Announces Final Data From Randomized Head-to-Head[...]
Ollin Biosciences Inc

Ollin Biosciences Announces Upcoming Presentations of 20-week Data from[...]

Company News

Ollin Biosciences Inc

02/07/2026 | Press release | Archived content

(Video) Angiogenesis, Exudation, and Degeneration 2026 – Randomized Phase 1b Trial of OLN324 vs Faricimab – First-time results of the JADE trial

Dr. Charles Wykoff presents first time results of the JADE trial in wet AMD and DME.

https://vimeo.com/1162899346

Ollin Biosciences Inc published this content on February 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 29, 2026 at 06:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format